Conduction System Pacing Display Research During LBBAP Implant
Official title: Conduction System Pacing Display Research System for SmartSync Pacing System Analyzer
Run by Medtronic Cardiac Rhythm and Heart Failure · NCT07733960 · Data updated 2026-11-12
Researchers are testing a CSP Display System during left bundle branch area pacing pacemaker implant to see if it accurately shows heart signals compared with a standard ECG.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Medtronic Cardiac Rhythm and Heart Failure Industry-sponsored |
| Locations | 2 sites (Madurai, Tamil Nadu and 1 other locations) |
| Status | Recruiting |
| Started | May 21, 2026 |
| Main results expected | July 30, 2027 |
| Study ends | July 30, 2027 |
| Registry record updated | July 29, 2026 |
| Trial ID | NCT07733960 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) undergoing de-novo single- or dual-chamber pacemaker implantation with left bundle branch area pacing who can provide informed consent.
✕Probably not a fit
Patients who are not undergoing LBBAP implants or who do not meet the imaging/measurement criteria may not benefit from this feasibility testing.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a feasibility, observational study conducted during de-novo LBBAP pacemaker implants to compare the CSP Display Research System's ECG visualization and left ventricular activation time measurements with those obtained from a standard EP recording system. The study collects exploratory data such as ECG, intracardiac signals, pacemaker marker channels, and LV activation times to support future research and algorithm development. No pre-specified endpoints are evaluated beyond descriptive comparisons and data collection during the implant procedure. The CSP system is used as an adjunct in the procedure, with measurements analyzed against standard clinical practice for feasibility purposes.
Why it matters
Potential benefit: If successful, the CSP Display System could help clinicians visualize and quantify cardiac activation during LBBAP implantation, potentially aiding planning and validation of pacing approaches.
How similar studies have gone: Previous studies in device-assisted electrophysiology have shown promise for CSP-based visualization, but this specific CSP Display System feasibility work is exploratory and incremental.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subject is at least 18 years of age * Subject is willing and able to provide written informed consent * Subject is willing and able to comply with the protocol * Subject meets eligibility for de-novo implant of a pacemaker (single or dual chamber) with left bundle branch area pacing (LBBAP) therapy Exclusion Criteria: * Subject is not available to comply with visit schedule * Pregnant or breastfeeding woman (pregnancy test required for woman of child-bearing potential and who are not on a reliable form of birth regulation method or abstinence) * Subject is currently enrolled or planning to enroll in a concurrent study that may confound the results of this study. Pre-approval from the study manager is required for enrollment of a patient that is in a concurrent study. * Subject meets any exclusion criteria required by local law * Vulnerable adults (i.e. subjects incapable of giving consent)
Where it's running
-
Velammal Medical College Hospital and Research Institute
Madurai, Tamil Nadu, India Recruiting -
Asian Institute of Gastroenterology(AIG) hospitals
Hyderabad, Telegana, India Recruiting
Study contacts
- Study coordinator: Sr Director - Clinical Research and Medical Science, Medtronic
- Email: vinay.rajan@medtronic.com
- Phone: +91-2233074700
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SPIKE FLOW endocardial pacing lead safety and performance study
This study tests whether the SPIKE FLOW temporary endocardial pacing lead is safe and effective in adults needing temporary pacing during heart-related conditions.
-
Factors Linked to Slow Heart Rate After Pulsed Field Ablation for Atrial Fibrillation
This study looks for factors that might cause bradycardia during the hospital stay after AF ablation using pulsed field technology.
-
Transjugular implantation of a leadless pacemaker (Aveir VR) for ventricular pacing
This study tests whether placing an Aveir VR leadless pacemaker through the neck vein can safely provide ventricular pacing in adults with bradycardia.
-
Focal Cryoablation vs. Radiofrequency Cardioneuroablation for Bradyarrhythmias
This study tests whether focal cryoablation can treat vagally driven slow heart rhythms as well as traditional radiofrequency ablation in adults with bradycardia or related syncope.
-
Personalized pacing rate to see if higher lower rate helps heart and brain flow
In hypertensive patients with bradycardia who need a dual-chamber pacemaker, the study tests whether setting a higher, personalized pacing rate improves heart function and brain blood flow compared with the standard 60 bpm.
-
Permanent Conduction System Pacing vs Native Conduction in Wide QRS with Intermittent Bradycardia
This study tests whether conduction system pacing can better preserve heart function than native conduction in adults with wide QRS and intermittent bradycardia who need a pacemaker.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.